Literature DB >> 7567192

Kawasaki disease.

S T Shulman1, J De Inocencio, R Hirsch.   

Abstract

This article is an up-to-date review of issues surrounding Kawasaki disease, with particular emphasis on the immunologic aspects. Kawasaki disease is now the leading cause of acquired heart disease in children in most developed countries.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7567192     DOI： 10.1016/s0031-3955(16)40059-3

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN： 0031-3955            Impact factor:   3.278


  38 in total

1.  Kawasaki disease.

Authors:  S Saraf; R K Singh
Journal:  Indian J Pediatr       Date:  2001-10       Impact factor: 1.967

2.  Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research.

Authors:  P A Brogan; A Bose; D Burgner; D Shingadia; R Tulloh; C Michie; N Klein; R Booy; M Levin; M J Dillon
Journal:  Arch Dis Child       Date:  2002-04       Impact factor: 3.791

3.  Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease.

Authors:  J Kimura; H Takada; A Nomura; T Ohno; Y Mizuno; M Saito; K Kusuhara; T Hara
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

4.  High concentrations of interleukin-8 and monocyte chemoattractant protein-1 in urine of patients with acute Kawasaki disease.

Authors:  Toshiaki Jibiki; Masaru Terai; Yoichi Kohno
Journal:  Eur J Pediatr       Date:  2004-12       Impact factor: 3.183

5.  [Manifestations of autoimmune disorders in otorhinolaryngology : Classical symptoms and diagnostic approach].

Authors:  B Hofauer; A Chaker; K Thürmel; A Knopf
Journal:  HNO       Date:  2017-08       Impact factor: 1.284

6.  Coronary involvement in infants with Kawasaki disease treated with intravenous gamma-globulin.

Authors:  Noelia Moreno; Ana Méndez-Echevarría; Jaime de Inocencio; Fernando Del Castillo; Fernando Baquero-Artigao; María Jesús García-Miguel; María Isabel de José; Javier Aracil
Journal:  Pediatr Cardiol       Date:  2007-10-05       Impact factor: 1.655

7.  Acute severe hepatitis with coagulopathy: An unusual presentation of Kawasaki syndrome in association with Epstein-Barr virus.

Authors:  M M Gordon; E D Silverman; J H Kim; A M Huber; K Furuya
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

Review 8.  Genetic polymorphisms in Kawasaki disease.

Authors:  Ho-chang Kuo; Wei-chiao Chang
Journal:  Acta Pharmacol Sin       Date:  2011-09-05       Impact factor: 6.150

Review 9.  Nonatherosclerotic causes of myocardial ischemia.

Authors:  A E Iskandrian; N Nallamothu; J Heo
Journal:  J Nucl Cardiol       Date:  1996 Sep-Oct       Impact factor: 5.952

10.  Pelviureteric junction obstruction as sequelae of Kawasaki disease.

Authors:  R Subramaniam; T Lama; C Y Chong
Journal:  Pediatr Surg Int       Date:  2004-07-10       Impact factor: 1.827
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.